0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover1187.69%IV-560.79%PremiumJul 19, 2024Expiry Date2.55Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7429Delta0.5105Gamma0.17Leverage Ratio-0.0194Theta-0.0003Rho-0.13Eff Leverage0.0002Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet